Matrix metalloproteinases: Pathways of induction by bioactive molecules

Toshihiro Tsuruda, Lisa C. Costello-Boerrigter, John C Jr. Burnett

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Regulation of the extracellular matrix (ECM) is an important therapeutic target that can potentially attenuate the adverse ventricular remodeling seen in the progression of heart failure. Matrix metalloproteinases (MMPs) degrade numerous ECM proteins. Importantly, the activation of MMPs and their endogenous inhibitors (TIMPs) are associated with ventricular remodeling. Bioactive-molecules (vasoactive peptides) become activated in proportion to the magnitude of heart failure and have been demonstrated to affect directly collagen degradation as well as collagen synthesis in the myocardium. Pro-fibrotic factors such as norepinephrine, angiotensin II, and endothelin-1 stimulate fibrosis by modulating collagen synthesis and MMP/TIMP activity. Antagonism of these bioactive-molecules has produced improved hemodynamic performance concomitant with modulation of MMP/TIMP activity and in association with reverse remodeling. The natriuretic peptides and nitric oxide, both of which function via the second messenger cGMP, demonstrate anti-fibiotic actions by inhibiting collagen synthesis and by stimulating MMP activity. Furthermore, bioactive-molecules along with certain cytokines are reported to amplify MMP activity, suggesting that different signaling systems work together to modulate ECM turnover. Taken together, the evidence supports an important functional role for bioactive-molecules in the regulation of ECM turnover and suggests that pharmacological intervention at the level of such bioactive molecules may provide potential therapeutic strategies for attenuation of the adverse ventricular remodeling associated with the progression of heart failure.

Original languageEnglish (US)
Pages (from-to)53-61
Number of pages9
JournalHeart Failure Reviews
Volume9
Issue number1
DOIs
StatePublished - Jan 2004

Fingerprint

Matrix Metalloproteinases
Ventricular Remodeling
Collagen
Extracellular Matrix
Heart Failure
Natriuretic Peptides
Extracellular Matrix Proteins
Second Messenger Systems
Endothelin-1
Angiotensin II
Myocardium
Norepinephrine
Nitric Oxide
Fibrosis
Hemodynamics
Pharmacology
Cytokines
Peptides
Therapeutics

Keywords

  • Collagen
  • Degradation
  • Fibrosis
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Matrix metalloproteinases : Pathways of induction by bioactive molecules. / Tsuruda, Toshihiro; Costello-Boerrigter, Lisa C.; Burnett, John C Jr.

In: Heart Failure Reviews, Vol. 9, No. 1, 01.2004, p. 53-61.

Research output: Contribution to journalArticle

Tsuruda, Toshihiro ; Costello-Boerrigter, Lisa C. ; Burnett, John C Jr. / Matrix metalloproteinases : Pathways of induction by bioactive molecules. In: Heart Failure Reviews. 2004 ; Vol. 9, No. 1. pp. 53-61.
@article{578e189a488848b5b10cb0444185f468,
title = "Matrix metalloproteinases: Pathways of induction by bioactive molecules",
abstract = "Regulation of the extracellular matrix (ECM) is an important therapeutic target that can potentially attenuate the adverse ventricular remodeling seen in the progression of heart failure. Matrix metalloproteinases (MMPs) degrade numerous ECM proteins. Importantly, the activation of MMPs and their endogenous inhibitors (TIMPs) are associated with ventricular remodeling. Bioactive-molecules (vasoactive peptides) become activated in proportion to the magnitude of heart failure and have been demonstrated to affect directly collagen degradation as well as collagen synthesis in the myocardium. Pro-fibrotic factors such as norepinephrine, angiotensin II, and endothelin-1 stimulate fibrosis by modulating collagen synthesis and MMP/TIMP activity. Antagonism of these bioactive-molecules has produced improved hemodynamic performance concomitant with modulation of MMP/TIMP activity and in association with reverse remodeling. The natriuretic peptides and nitric oxide, both of which function via the second messenger cGMP, demonstrate anti-fibiotic actions by inhibiting collagen synthesis and by stimulating MMP activity. Furthermore, bioactive-molecules along with certain cytokines are reported to amplify MMP activity, suggesting that different signaling systems work together to modulate ECM turnover. Taken together, the evidence supports an important functional role for bioactive-molecules in the regulation of ECM turnover and suggests that pharmacological intervention at the level of such bioactive molecules may provide potential therapeutic strategies for attenuation of the adverse ventricular remodeling associated with the progression of heart failure.",
keywords = "Collagen, Degradation, Fibrosis, Heart failure",
author = "Toshihiro Tsuruda and Costello-Boerrigter, {Lisa C.} and Burnett, {John C Jr.}",
year = "2004",
month = "1",
doi = "10.1023/B:HREV.0000011394.34355.bb",
language = "English (US)",
volume = "9",
pages = "53--61",
journal = "Heart Failure Reviews",
issn = "1382-4147",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Matrix metalloproteinases

T2 - Pathways of induction by bioactive molecules

AU - Tsuruda, Toshihiro

AU - Costello-Boerrigter, Lisa C.

AU - Burnett, John C Jr.

PY - 2004/1

Y1 - 2004/1

N2 - Regulation of the extracellular matrix (ECM) is an important therapeutic target that can potentially attenuate the adverse ventricular remodeling seen in the progression of heart failure. Matrix metalloproteinases (MMPs) degrade numerous ECM proteins. Importantly, the activation of MMPs and their endogenous inhibitors (TIMPs) are associated with ventricular remodeling. Bioactive-molecules (vasoactive peptides) become activated in proportion to the magnitude of heart failure and have been demonstrated to affect directly collagen degradation as well as collagen synthesis in the myocardium. Pro-fibrotic factors such as norepinephrine, angiotensin II, and endothelin-1 stimulate fibrosis by modulating collagen synthesis and MMP/TIMP activity. Antagonism of these bioactive-molecules has produced improved hemodynamic performance concomitant with modulation of MMP/TIMP activity and in association with reverse remodeling. The natriuretic peptides and nitric oxide, both of which function via the second messenger cGMP, demonstrate anti-fibiotic actions by inhibiting collagen synthesis and by stimulating MMP activity. Furthermore, bioactive-molecules along with certain cytokines are reported to amplify MMP activity, suggesting that different signaling systems work together to modulate ECM turnover. Taken together, the evidence supports an important functional role for bioactive-molecules in the regulation of ECM turnover and suggests that pharmacological intervention at the level of such bioactive molecules may provide potential therapeutic strategies for attenuation of the adverse ventricular remodeling associated with the progression of heart failure.

AB - Regulation of the extracellular matrix (ECM) is an important therapeutic target that can potentially attenuate the adverse ventricular remodeling seen in the progression of heart failure. Matrix metalloproteinases (MMPs) degrade numerous ECM proteins. Importantly, the activation of MMPs and their endogenous inhibitors (TIMPs) are associated with ventricular remodeling. Bioactive-molecules (vasoactive peptides) become activated in proportion to the magnitude of heart failure and have been demonstrated to affect directly collagen degradation as well as collagen synthesis in the myocardium. Pro-fibrotic factors such as norepinephrine, angiotensin II, and endothelin-1 stimulate fibrosis by modulating collagen synthesis and MMP/TIMP activity. Antagonism of these bioactive-molecules has produced improved hemodynamic performance concomitant with modulation of MMP/TIMP activity and in association with reverse remodeling. The natriuretic peptides and nitric oxide, both of which function via the second messenger cGMP, demonstrate anti-fibiotic actions by inhibiting collagen synthesis and by stimulating MMP activity. Furthermore, bioactive-molecules along with certain cytokines are reported to amplify MMP activity, suggesting that different signaling systems work together to modulate ECM turnover. Taken together, the evidence supports an important functional role for bioactive-molecules in the regulation of ECM turnover and suggests that pharmacological intervention at the level of such bioactive molecules may provide potential therapeutic strategies for attenuation of the adverse ventricular remodeling associated with the progression of heart failure.

KW - Collagen

KW - Degradation

KW - Fibrosis

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=1042292006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1042292006&partnerID=8YFLogxK

U2 - 10.1023/B:HREV.0000011394.34355.bb

DO - 10.1023/B:HREV.0000011394.34355.bb

M3 - Article

C2 - 14739768

AN - SCOPUS:1042292006

VL - 9

SP - 53

EP - 61

JO - Heart Failure Reviews

JF - Heart Failure Reviews

SN - 1382-4147

IS - 1

ER -